Multiplex Assay and Markers of Metastatic Bone Disease
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F13%3A10281518" target="_blank" >RIV/00216208:11140/13:10281518 - isvavai.cz</a>
Alternative codes found
RIV/00669806:_____/13:10281518
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Multiplex Assay and Markers of Metastatic Bone Disease
Original language description
A multiplex panel for the measurement of serum levels, including osteoprotegerin, osteopontin, osteocalcin, parathormon and leptin, was tested in a group of cancer patients with metastatic disease, and in healthy controls using xMAP technology.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NT13655" target="_blank" >NT13655: Biomarkers of Bone Metastatic Disease</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
Proceedings of the 2nd International Congress on Personalized Medicine UPCP 2013
ISBN
978-88-7587-703-3
ISSN
—
e-ISSN
—
Number of pages
6
Pages from-to
15-20
Publisher name
MEDIMOND s.r.l.
Place of publication
Bologna, Italy
Event location
Paris, France
Event date
Jun 25, 2013
Type of event by nationality
WRD - Celosvětová akce
UT code for WoS article
000342205300003